Introduction
The quest for inhibitors of glycogen phosphorylases (GPs) has 50 been based on and fuelled by the potential application of such compounds as medication in type II diabetes mellitus [1] [2] [3] and also as possible therapeutic means in other diseased states like myocardial 4, 5 and cerebral 6, 7 ischemias and tumors. [8] [9] [10] [11] A large variety of compounds targeting one of the six binding sites of GP (catalytic, inhibitor, allosteric, new allosteric, storage and benzimidazole sites) have been developed to reach the nanomolar range in their inhibitory efficiency. 3, 12 Catalytic site inhibitors are almost exclusively glucose derivatives 13 which have been designed and studied following the observation that both anomeric 60 forms of D-glucose (A and B in Chart 1) are modest inhibitors of GP.
14 Early inhibitor design resulted in glucopyranosylidene-spiro-hydantoins C and D with low micromolar inhibition constants. 15, 16 Most efficient representatives of N-glucopyranosyl-1,2,3-triazoles 17,18 E and C-glucopyranosyl-benzimidazoles [19] [20] [21] F proved similarly or somewhat less effective than the hydantoins. Among the recently designed and synthesized 5-b-D-glucopyranosyl-3-substituted-1,2,4-triazoles submicromolar inhibitors of GP (e.g., G) were found. 22, 23 Best compounds in series of other types of anomeric spirocycles like isoxazolines 24 (e.g., H) and oxathiazoles 25, 26 (e.g.,
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I) showed inhibition approaching the low nanomolar range. To explain the strong binding of these compounds extensive interactions with the so-called b-channel of the enzyme were invoked besides the ideal fit of the sugar moiety in the catalytic site. 12, 13 Thus, the increasing binding strength must largely be attributed to the aglycon part of the molecules. Investigations into the specificity of GP towards various monosaccharides revealed that changes in the sugar configuration or constitution resulted in a significant decrease of the inhibition: for example, D-xylose (J) proved a $13-60-fold weaker inhibitor 80 in comparison to the D-glucose anomers A and B. 27 Since the efficiency of the glucose derived inhibitors depended to a large extent on the fit of the aglycon in the b-channel, the D-xylo configured analogues of the best inhibitors were time to time synthesized and tested against GP to check if the interactions of the aglycon might overbalance the worse binding of the 'truncated' glycon.
Up to now xylopyranosylidene-spiro-hydantoins 16 K and L as well as N-(b-D-xylopyranosyl)-1,2,3-triazoles (e.g., M) together with similar derivatives of 5-thio-xylose and the related cyclic sulfoxides and sulfones 28 were studied, however, showed no significant 90 effect against RMGPb.
In this paper we report on the synthesis and enzymatic evaluation of xylose derived analogues N-Q of the best glucose based inhibitors of rabbit muscle glycogen phosphorylase b.
Results and discussion
For the preparation of the desired C-xylosyl benzimidazole N, our recently published reaction sequence was applied. 21 Thus, 2,3,4-tri-O-benzoyl-b-D-xylopyranosyl cyanide 29 (1, Scheme 1) was hydrated to anhydro-aldonamide 2 which, on treatment by Et 3 OÁBF 4 gave ethyl imidate 3. Reaction of 3 with 1,2-diamino-ben-100 zene furnished the protected benzimidazole 4 which was O-debenzoylated under Zemplén conditions 30 to give the test compound 5.
Structure elucidation of the compounds was straightforward by NMR methods, and it is to be noted that line broadening of some resonances in the 13 C spectra, due to fast proton exchange of the two nitrogens, was observed similarly to earlier experiences. 21 Next, to get an intermediate for the preparation of C-xylosyl-1,2,4-triazoles O, imidate 3 was reacted with tosylhydrazine, 22, 31 however, instead of the expected N 1 -tosyl-(C-xylopyranosyl)formamidrazone only its benzoic acid elimination product 6 could be 110 isolated.
Therefore, we turned to an alternative route 23 (Scheme 2) and, to this end, 1 was transformed to tetrazole à 7 by TMSN 3 -Bu 2 SnO. 33 Reactions of 7 with non-purified N-benzyl-arenecarboximidoyl For the preparation of xylopyranosylidene-spiro-isoxazolines P, O-peracetylated b-D-xylopyranosyl cyanide 34 20 was transformed to the corresponding anhydro-aldose tosylhydrazone 21 by applying our published method. 35, 36 Bamford-Stevens reaction 37 Synthesis of the xylopyranosylidene-spiro-oxathiazoles Q was started by the conversion of O-peracetylated 1-thio-b-D-xylopyranose 41 35 to S-b-D-xylopyranosyl thiohydroximates 36-38 (Scheme 4). One of the generally applied methods to get S-glycosyl 140 thiohydroximates 42 is the reaction of the corresponding 1-thiosugars with nitrile-oxides. In addition to the above mentioned oxidative processes, a frequently used way to obtain nitrile-oxides in situ is the base-induced dehydrohalogenation of hydroximoyl halides which are isolable after halogenation (by e.g., Cl 2 , NCS or NBS) of aldoximes. 39 Because of the sensitivity of thiols to oxidation, nitrile oxides were generated from hydroximoyl chlorides by Et 3 N (method a in Scheme 4) in the presence of 35. A recently reported procedure to perform the chlorination and HCl elimination in one continuous operation (method b), suggested to be supe-
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rior especially for the preparation of glycosyl thiohydroximates, 43 was also studied. Although both methods gave good yields of the expected products 36-38, in our hands the conventional dehydrochlorination of the isolated hydroximoyl chlorides gave better results (compare yields for methods a and b in Scheme 4). Thiohydroximates 36-38 were deacetylated by the Zemplén method 30 to
give the test compounds 39-41. Ring closure of the thiohydroximates was effected by NBS under irradiation as reported for the preparation of several glycoenzyme inhibitors of this spiro-oxathiazole type. 26, 44, 45 Expectedly, the for-160 mation of two spiro epimers was observed, however, in contrast to earlier findings with hexopyranose derived compounds where the anomeric configuration of the thiohydroximate was retained in the major cyclized product, in these reactions compounds of the inverted configuration 42-44 were isolated as the main products. configurations were assigned by utilizing these coincidences. Enzymatic evaluation of the deprotected compounds against rabbit muscle glycogen phosphorylase b (RMGPb) was carried out as described before. 16 All but one of the deprotected xylose deriv- (35) , arenecarbaldoximes 47 and N-hydroxy-arenecarboximidoyl chlorides 47 were synthesized according to published procedures.
General procedure I for the Zemplén-deacylation 30
An O-acylated compound was dissolved in anhydrous MeOH 250 (5 mL/100 mg, a few drops of CHCl 3 were added in case of incomplete dissolution) and a catalytic amount of a NaOMe solution ($1 M in MeOH) was added. The mixture was kept at rt and monitored by TLC (7:3 CHCl 3 -MeOH). After disappearance of the starting material the mixture was neutralized with a cation exchange resin Amberlyst 15 (H + form), then the resin was filtered off and the solvent removed. The residue was purified either by column chromatography or by crystallization. 
1-Naphthyl (43) 2-Naphthyl (44) Ph (50) 1-Naphthyl (51)
Ph (45) 1-Naphthyl (46) 2-Naphthyl (47) off the excess of SOCl 2 under reduced pressure, anhydrous toluene (20 mL) was evaporated from the residue. 5-(2,3,4-Tri-O-benzoylb-D-xylopyranosyl)tetrazole (7, 1.54 mmol, 1 equiv) and anhydrous toluene or m-xylene (20 mL) were added, the mixture was heated to reflux temperature and the reaction was monitored by TLC (1:1 EtOAc-hexane). After total consumption of the tetrazole the solvent was removed and the residue was purified by column 270 chromatography.
General procedure III for the removal of benzyl protecting groups
A benzylated compound (0.5 mmol) was dissolved in anhydrous MeOH (25 mL), 10% Pd(C) (20 mg) was added and H 2 gas was bubbled through the reaction mixture at 50°C. After disappearance of the starting material (monitored by TLC, 7:3 CHCl 3 -MeOH) the reaction mixture was filtered through a pad of Celite, the solvent was evaporated and the residue was purified by column chromatography. 3.5. General procedure IV for the synthesis of (1
, 100 mg, 0.37 mmol) and an arenecarbaldoxime (1.85 mmol, 5 equiv) were dissolved in THF (4.8 mL) under N 2 atmosphere. To this stirred solution domestic bleach (5% available chlorine, 3.86 mL) was added with a syringe pump in 5 h at rt. The reaction was stirred for additional 24 h. After complete disappearance of the starting exo-xylal (TLC, 1:1 EtOAc-hexane) the reaction was 290 diluted with EtOAc (20 mL), the phases were separated and the organic layer was washed with water (3 Â 15 mL), dried over MgSO 4 and the solvent was evaporated under reduced pressure. The residue was purified by column chromatography (1:3 EtOAchexane).
3.6. General procedure V (method a) for the synthesis of 2,3,4- (35, 0.29 g, 1 mmol) and the corresponding N-hydroxy-arenecarboximidoyl 300 chloride (1.5 mmol) were dissolved in anhydrous CH 2 Cl 2 (10 mL), Et 3 N was added (3 mmol) and the reaction mixture was stirred at rt under Ar. After completion of the reaction (1.5 h, monitored by TLC, 1:2 EtOAc-hexane) the mixture was treated with 2 M HCl solution (20 mL), then the separated organic phase was washed with water (2 Â 20 mL). The organic layer was dried over MgSO 4 , filtered and evaporated. The residue was purified by column chromatography (1:2 EtOAc-hexane) to give an oil that was crystallized from hexane.
General procedure VI (method b)
43 for the synthesis of
An arenecarbaldoxime (1.5 mmol) was dissolved in CH 2 Cl 2 (10 mL) and the solution was extracted with domestic bleach (5% available chlorine, 5 mL). After drying over MgSO 4 the organic phase was added dropwise to a solution of 2,3,4-tri-O-acetyl-1-thio-b-D-xylopyranose 41 (35, 0.29 g, 1 mmol) in CH 2 Cl 2 (10 mL).
After addition of Et 3 N (3 mmol) the reaction mixture was stirred at rt under Ar, and monitored by TLC (1:2 EtOAc-hexane). When the starting material was consumed (1.5 h) the mixture was trea-320 ted with 2 M HCl solution (20 mL), then the separated organic phase was washed with water (2 Â 20 mL). The organic layer was dried over MgSO 4 , filtered and evaporated. The residue was purified by column chromatography (1:2 EtOAc-hexane) to give an oil that was crystallized from hexane.
3.8. General procedure VII for the synthesis of (1 anhydrous CHCl 3 (20 mL) and the mixture was boiled and illuminated by a 250 W heat lamp. When TLC (1:2 EtOAc-hexane) showed total consumption of the starting material (1 h) the reaction mixture was diluted with CHCl 3 (30 mL), extracted with satd aq Na 2 S 2 O 4 solution (40 mL), satd aq NaHCO 3 solution (40 mL) and water (40 mL). The organic layer was dried over MgSO 4 , filtered and evaporated under reduced pressure. The residue was purified by column chromatography.
3.9. Synthesis and characterization of the compounds
(1, 3.0 g, 6.4 mmol) was suspended in a solution of HBr in AcOH (8 mL, 33% m/m) and the mixture was stirred at rt. After disappearance of the starting material (3 h, monitored by TLC, 1:1 EtOAc-hexane) the reaction mixture was poured into ice-water (40 mL) and extracted with CHCl 3 (2 Â 30 mL). The combined organic phases were washed with satd aq NaHCO 3 solution (2 Â 30 mL), then with water (30 mL), dried over MgSO 4 
04 mmol) and Et 3 OÁBF 4 (1.16 g, 6.13 mmol, 3 equiv) were stirred in anhydrous CH 2 Cl 2 (15 mL) at rt under Ar, and monitored by TLC (1:1 EtOAc-hexane). After completion of the reaction (24 h), the mixture was diluted with CH 2 Cl 2 (50 mL), extracted with satd aq NaHCO 3 solution (40 mL) and then with water (40 mL). The organic phase was dried over MgSO 4 , filtered and the solvent was removed under diminished pressure. The pale yellow amorphous crude product (1.02 g, 96%) was used without further purification. 
76 mmol) and p-toluenesulfonylhydrazide (0.21 g, 1.13 mmol, 1.5 equiv) were dissolved in anhydrous CH 2 Cl 2 (12 mL), stirred at rt and monitored by TLC (1:1 EtOAc-hexane). After completion of the reaction (3 days) the solvent was evaporated, and the residue was purified by column chromatography (4:7 EtOAc-hexane). The resulting pale yellow oil was crystallized 3.9.6. 5-(2 0 ,3 
4-Benzyl-3-(4-tert-butylphenyl)-5-(b-D-xylopyranosyl)-1,2,4-triazole (15)
Triazole 12 (0.53 g, 0.63 mmol) was dissolved in anhydrous MeOH (4 mL), 1 M NaOH/MeOH (3 mL) was added and the mixture was refluxed for 1 h. The excess of NaOH was neutralized by AcOH. After evaporation the crude product was purified by column chromatography (9:1 CHCl 3 -MeOH) to yield 0.19 g (63%) white amorphous solid. 
C-(2,3,4-Tri-O-acetyl-b-D-xylopyranosyl)formaldehydetosylhydrazone (21)
To a vigorously stirred solution of pyridine (10 mL), AcOH (6 mL) and water (6 mL) an aqueous suspension of Raney-Ni (2.60 g) was added at rt. In a flame-dried three-necked flask NaH (95%, 44 mg, 1.75 mmol) was added to anhydrous 1,4-dioxane. This stirred suspension was heated to reflux and a solution of 21 (200 mg, 0.44 mmol) in anhydrous 1,4-dioxane (13 mL) was added dropwise during 1.5 h. The reaction was refluxed until the complete disappearance of the starting material (TLC, 1:1 EtOAc-hexane). After cooling to rt the insoluble material was filtered off and washed with anhydrous 1,4-dioxane (10 mL). The filtrate was concentrated under reduced pressure and the residue was purified by column chromatography 
From compound 22 (100 mg, 0.37 mmol) and 4-(trifluoromethyl)benzaldoxime (327 mg, 1.85 mmol) according to General procedure IV (Section 3.5) to yield 96 mg (57%) white amorphous solid. 
From compound 22 (100 mg, 0.37 mmol) and 1-naphthaldoxime (316 mg, 1.85 mmol) according to General procedure IV (Section 3.5) to yield 100 mg (60%) white amorphous solid. 
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